THR-18

DRUG3 trials

Sponsors

Thrombotech Ltd., D-Pharm Ltd.

Conditions

Acute Ischemic StrokeIschemic StrokeStroke, Acute

Phase 1

Study to Assess the Safety and Efficacy of THR-18 When Administered to Patients Suffering Acute Ischemic Stroke and Treated With Tissue Plasminogen Activator (tPA)

Thrombotech Ltd.Acute Ischemic Stroke

Start: 2011-03-31End: 2011-12-31Target: 22Updated: 2010-12-03

Phase 2

THR-18's Pharmacokinetics and Pharmacodynamics in Subjects With Acute Ischemic Stroke Treated With tPA

CompletedNCT01957774

D-Pharm Ltd.Stroke, Acute

Start: 2013-10-31Updated: 2015-02-04

A Study of the Safety, Imaging and Clinical Outcomes of THR-18 in Acute Stroke Subjects Treated With tPA

D-Pharm Ltd.Ischemic Stroke

Start: 2015-10-31End: 2016-04-30Target: 40Updated: 2015-11-17